Ron Ortiz Email

Director, Pharmaceutics . Imbrium Therapeutics

Current Roles

Employees:
37
Revenue:
$5.7M
About
Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. As an operating subsidiary of Purdue Pharma L.P., Imbrium strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians and health systems worldwide. We have built a robust and diversified pipeline of investigational drug candidates, and we actively collaborate with industry and academic partners to identify and advance future impactful medicines.
Imbrium Therapeutics Address
201 Tresser Boulevard
Stamford, CT
Imbrium Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.